PIVOTAL, PHASE 2B RENEU TRIAL OF MIRDAMETINIB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1-ASSOCIATED PLEXIFORM NEUROFIBROMA (NF1-PN): A SPOTLIGHT ON PATIENTS ACHIEVING DEEP RESPONSE

Overview

cited authors

Gershon, Timothy; Moertel, Christopher; McNall-Knapp, Rene; Shuhaiber, Hans; Weintraub, Lauren; Hajjar, Fouad; Nickerson, Molly; Weber, Michael; Lokku, Armend; Babovic-Vuksanovic, Dusica; Hirbe, Angela

Publication Date

November 11, 2024

webpage

Web of Science

published in

NEURO-ONCOLOGY Journal

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.